Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis
- 1 October 2002
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 123 (4), 1006-1012
- https://doi.org/10.1053/gast.2002.36013
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisThe New England Journal of Medicine, 2000
- Non-Steroidal Anti-Inflammatory Drugs and Ulcer Complications: a Risk Factor Analysis for Clinical Decision-MakingScandinavian Journal of Gastroenterology, 1996
- Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory DrugsAnnals of Internal Medicine, 1995
- Analysis of Long-Term Adverse Experience Data Using the Weibull ModelDrug Information Journal, 1994
- Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory DrugsAnnals of Internal Medicine, 1991
- Use of Many Covariates in Clinical TrialsInternational Statistical Review, 1991
- Corticosteroid Use and Peptic Ulcer Disease: Role of Nonsteroidal Anti-inflammatory DrugsAnnals of Internal Medicine, 1991
- Nonsteroidal Anti-inflammatory Drug Use and Increased Risk for Peptic Ulcer Disease in Elderly PersonsAnnals of Internal Medicine, 1991
- The Effect of Chronic Aspirin Use on Duodenal and Gastric Ulcer HospitalizationsJournal of Clinical Gastroenterology, 1990